Compumedics (ASX:CMP) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Compumedics Dividend Payout Ratio?

Compumedics's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Compumedics's Dividend Payout Ratio or its related term are showing as below:

ASX:CMP's Dividend Payout Ratio is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.43
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-04), the Dividend Yield % of Compumedics is 0.00%.

Compumedics's Dividends per Share for the months ended in Dec. 2023 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Compumedics Dividend Payout Ratio Historical Data

The historical data trend for Compumedics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compumedics Dividend Payout Ratio Chart

Compumedics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Dividend Payout Ratio

Get a 7-Day Free Trial

Compumedics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Compumedics's Dividend Payout Ratio

For the Medical Devices subindustry, Compumedics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Compumedics's Dividend Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Compumedics's Dividend Payout Ratio falls into.

Compumedics Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Compumedics's Dividend Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jun. 2023 )	/	EPS without NRI (A: Jun. 2023 )
	=	0	/	-0.019
	=	N/A

Compumedics's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	Earnings per Share (Diluted) (Q: Dec. 2023 )
	=	0	/	0.001
	=	0.00

Compumedics (ASX:CMP) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Compumedics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Compumedics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Compumedics (ASX:CMP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Compumedics Ltd (ASX:CMP) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.compumedics.com.au

Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.